Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124991823 | 12499182 | 3 | F | 20160415 | 20160712 | 20160627 | 20160718 | EXP | PHHY2016BR062429 | NOVARTIS | 77.14 | YR | F | Y | 58.00000 | KG | 20160719 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124991823 | 12499182 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 4.6 MG (PATCH 5 CM2), QD | U | 630110 | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||
| 124991823 | 12499182 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 9.5 MG (PATCH 10 CM2), QD | U | 689210 | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||
| 124991823 | 12499182 | 3 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 88 MG, QD (1 TABLET DAILY) | 0 | 88 | MG | TABLET | QD | ||||||
| 124991823 | 12499182 | 4 | C | ESCITALOPRAM OXALATE. | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG, QD (1 TABLET DAILY) | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124991823 | 12499182 | 1 | Dementia Alzheimer's type |
| 124991823 | 12499182 | 3 | Thyroidectomy |
| 124991823 | 12499182 | 4 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124991823 | 12499182 | HO |
| 124991823 | 12499182 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124991823 | 12499182 | Abdominal discomfort | |
| 124991823 | 12499182 | Application site erythema | |
| 124991823 | 12499182 | Application site irritation | |
| 124991823 | 12499182 | Application site pruritus | |
| 124991823 | 12499182 | Asthenia | |
| 124991823 | 12499182 | Blood pressure increased | |
| 124991823 | 12499182 | Headache | |
| 124991823 | 12499182 | Limb discomfort | |
| 124991823 | 12499182 | Malaise | |
| 124991823 | 12499182 | Muscle spasms | |
| 124991823 | 12499182 | Nausea | |
| 124991823 | 12499182 | Product adhesion issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |